ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anthrax Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: May 2025
|
Report Code: QYRE-Auto-3N2926
Home | Market Reports | Health| Pharmacy
Global Anthrax Vaccines Market Insights Forecast to 2026
BUY CHAPTERS

Global Anthrax Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-3N2926
Report
May 2025
Pages:188
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Emergent Biosolutions
Merial 
Merck
Zoetis Inc
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC

Anthrax Vaccines Market Size

In 2024, the global market size of Anthrax Vaccines was estimated to be worth US$ 758 million and is forecast to reach approximately US$ 1256 million by 2031 with a CAGR of 7.6% during the forecast period 2025-2031.

Anthrax Vaccines Market

Anthrax Vaccines Market

Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
Global Anthrax Vaccines key players include Emergent BioSolutions, Merial, Merck, Zoetis, PharmAthene, etc. Global top five players hold a share about 70%.
North America is the largest market, with a share about 60%, followed by Latin America and Europe, having a total share about 20 percent.
In terms of product, Live Vaccines is the largest segment, with a share about 95%. And in terms of application, the largest application is Human Use, followed by Animal Use.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anthrax Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anthrax Vaccines.
The Anthrax Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anthrax Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anthrax Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Anthrax Vaccines Market Report

Report Metric Details
Report Name Anthrax Vaccines Market
CAGR 7.6%
Segment by Type
  • Live Vaccines
  • Cell free PA Vaccines
Segment by Application
  • Human Use
  • Animal Use
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Emergent BioSolutions, Merial, Merck, Zoetis, Bayer Sanidad Animal, Colorado Serum, PharmAthene, Tiankang, Biogénesis-Bago, CAVAC, Rosenbusch, Agrovet, Vecol, CVCRI, IVPM, Prondil, CDV, Indian Immunologicals, Botswana Vaccine Institute, Ceva Santé Animale, Intervac, JOVAC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Anthrax Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Anthrax Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anthrax Vaccines sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the market share of major companies in Anthrax Vaccines Market?

Ans: Global top five players hold a share about 70%.

What is the Anthrax Vaccines Market share by type?

Ans: In terms of product, Live Vaccines is the largest segment, with a share about 95%.

Who are the main players in the Anthrax Vaccines Market report?

Ans: The main players in the Anthrax Vaccines Market are Emergent BioSolutions, Merial, Merck, Zoetis, Bayer Sanidad Animal, Colorado Serum, PharmAthene, Tiankang, Biogénesis-Bago, CAVAC, Rosenbusch, Agrovet, Vecol, CVCRI, IVPM, Prondil, CDV, Indian Immunologicals, Botswana Vaccine Institute, Ceva Santé Animale, Intervac, JOVAC

What are the Application segmentation covered in the Anthrax Vaccines Market report?

Ans: The Applications covered in the Anthrax Vaccines Market report are Human Use, Animal Use

What are the Type segmentation covered in the Anthrax Vaccines Market report?

Ans: The Types covered in the Anthrax Vaccines Market report are Live Vaccines, Cell free PA Vaccines

Recommended Reports

Human Vaccine Markets

Animal Vaccine Markets

Innovative Vaccine Markets

1 Study Coverage
1.1 Anthrax Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Anthrax Vaccines Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Live Vaccines
1.2.3 Cell free PA Vaccines
1.3 Market by Application
1.3.1 Global Anthrax Vaccines Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Human Use
1.3.3 Animal Use
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anthrax Vaccines Market Size Estimates and Forecasts
2.1.1 Global Anthrax Vaccines Revenue 2020-2031
2.1.2 Global Anthrax Vaccines Sales 2020-2031
2.2 Anthrax Vaccines Market Size by Region: 2024 Versus 2031
2.3 Anthrax Vaccines Sales by Region (2020-2031)
2.3.1 Global Anthrax Vaccines Sales by Region: 2020-2025
2.3.2 Global Anthrax Vaccines Sales Forecast by Region (2026-2031)
2.3.3 Global Anthrax Vaccines Sales Market Share by Region (2020-2031)
2.4 Anthrax Vaccines Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Anthrax Vaccines Revenue by Region: 2020-2025
2.4.2 Global Anthrax Vaccines Revenue Forecast by Region (2026-2031)
2.4.3 Global Anthrax Vaccines Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Anthrax Vaccines Sales by Type (2020-2031)
3.1.1.1 Global Anthrax Vaccines Sales Volume by Type (2020-2031)
3.1.1.2 Global Anthrax Vaccines Sales Market Share by Type (2020-2031)
3.1.2 Global Anthrax Vaccines Revenue by Type (2020-2031)
3.1.2.1 Global Anthrax Vaccines Revenue by Type (2020-2031)
3.1.2.2 Global Anthrax Vaccines Revenue Market Share by Type (2020-2031)
3.1.3 Anthrax Vaccines Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Anthrax Vaccines Sales by Application (2020-2031)
3.2.1.1 Global Anthrax Vaccines Sales Volume by Application (2020-2031)
3.2.1.2 Global Anthrax Vaccines Sales Market Share by Application (2020-2031)
3.2.2 Global Anthrax Vaccines Revenue by Application (2020-2031)
3.2.2.1 Global Anthrax Vaccines Revenue by Application (2020-2031)
3.2.2.2 Global Anthrax Vaccines Revenue Market Share by Application (2020-2031)
3.2.3 Anthrax Vaccines Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Live Vaccines of Anthrax Vaccines Revenue Market Share by Application
3.3.2 Cell free PA Vaccines of Anthrax Vaccines Revenue Market Share by Application
4 Global Anthrax Vaccines by Manufacturers
4.1 Global Top Anthrax Vaccines Manufacturers by Sales (2020-2025)
4.1.1 Global Anthrax Vaccines Sales by Manufacturer (2020-2025)
4.1.2 Global Anthrax Vaccines Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Anthrax Vaccines Manufacturers by Revenue (2020-2025)
4.2.1 Global Anthrax Vaccines Revenue by Manufacturer (2020-2025)
4.2.2 Global Anthrax Vaccines Revenue Share by Manufacturer (2020-2025)
4.3 Global Anthrax Vaccines Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Anthrax Vaccines Manufacturers Covered: Ranking by Revenue
4.4.2 Global Anthrax Vaccines Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Anthrax Vaccines Manufacturing Base Distribution, Product Type
4.5.1 Anthrax Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Anthrax Vaccines Market
4.5.3 Manufacturers Anthrax Vaccines Product Type and Application
4.5.4 Live Vaccines Market Sales of Anthrax Vaccines by Manufacturer
4.5.5 Cell free PA Vaccines Market Sales of Anthrax Vaccines by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Emergent BioSolutions
5.1.1 Emergent BioSolutions Company Information
5.1.2 Emergent BioSolutions Description, Business Overview
5.1.3 Emergent BioSolutions Anthrax Vaccines Products Offered
5.1.4 Emergent BioSolutions Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Emergent BioSolutions Anthrax Vaccines Sales by Product in 2024
5.1.6 Emergent BioSolutions Anthrax Vaccines Sales by Application in 2024
5.1.7 Emergent BioSolutions Anthrax Vaccines Sales by Geographic Area in 2024
5.1.8 Emergent BioSolutions Recent Developments
5.2 Merial
5.2.1 Merial Company Information
5.2.2 Merial Description, Business Overview
5.2.3 Merial Anthrax Vaccines Products Offered
5.2.4 Merial Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Merial Anthrax Vaccines Sales by Product in 2024
5.2.6 Merial Anthrax Vaccines Sales by Application in 2024
5.2.7 Merial Anthrax Vaccines Sales by Geographic Area in 2024
5.2.8 Merial Recent Developments
5.3 Merck
5.3.1 Merck Company Information
5.3.2 Merck Description, Business Overview
5.3.3 Merck Anthrax Vaccines Products Offered
5.3.4 Merck Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Merck Anthrax Vaccines Sales by Product in 2024
5.3.6 Merck Anthrax Vaccines Sales by Application in 2024
5.3.7 Merck Anthrax Vaccines Sales by Geographic Area in 2024
5.3.8 Merck Recent Developments
5.4 Zoetis
5.4.1 Zoetis Company Information
5.4.2 Zoetis Description, Business Overview
5.4.3 Zoetis Anthrax Vaccines Products Offered
5.4.4 Zoetis Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Zoetis Anthrax Vaccines Sales by Product in 2024
5.4.6 Zoetis Anthrax Vaccines Sales by Application in 2024
5.4.7 Zoetis Anthrax Vaccines Sales by Geographic Area in 2024
5.4.8 Zoetis Recent Developments
5.5 Bayer Sanidad Animal
5.5.1 Bayer Sanidad Animal Company Information
5.5.2 Bayer Sanidad Animal Description, Business Overview
5.5.3 Bayer Sanidad Animal Anthrax Vaccines Products Offered
5.5.4 Bayer Sanidad Animal Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Bayer Sanidad Animal Anthrax Vaccines Sales by Product in 2024
5.5.6 Bayer Sanidad Animal Anthrax Vaccines Sales by Application in 2024
5.5.7 Bayer Sanidad Animal Anthrax Vaccines Sales by Geographic Area in 2024
5.5.8 Bayer Sanidad Animal Recent Developments
5.6 Colorado Serum
5.6.1 Colorado Serum Company Information
5.6.2 Colorado Serum Description, Business Overview
5.6.3 Colorado Serum Anthrax Vaccines Products Offered
5.6.4 Colorado Serum Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Colorado Serum Anthrax Vaccines Sales by Product in 2024
5.6.6 Colorado Serum Anthrax Vaccines Sales by Application in 2024
5.6.7 Colorado Serum Anthrax Vaccines Sales by Geographic Area in 2024
5.6.8 Colorado Serum Recent Developments
5.7 PharmAthene
5.7.1 PharmAthene Company Information
5.7.2 PharmAthene Description, Business Overview
5.7.3 PharmAthene Anthrax Vaccines Products Offered
5.7.4 PharmAthene Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.7.5 PharmAthene Anthrax Vaccines Sales by Product in 2024
5.7.6 PharmAthene Anthrax Vaccines Sales by Application in 2024
5.7.7 PharmAthene Anthrax Vaccines Sales by Geographic Area in 2024
5.7.8 PharmAthene Recent Developments
5.8 Tiankang
5.8.1 Tiankang Company Information
5.8.2 Tiankang Description, Business Overview
5.8.3 Tiankang Anthrax Vaccines Products Offered
5.8.4 Tiankang Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Tiankang Anthrax Vaccines Sales by Product in 2024
5.8.6 Tiankang Anthrax Vaccines Sales by Application in 2024
5.8.7 Tiankang Anthrax Vaccines Sales by Geographic Area in 2024
5.8.8 Tiankang Recent Developments
5.9 Biogénesis-Bago
5.9.1 Biogénesis-Bago Company Information
5.9.2 Biogénesis-Bago Description, Business Overview
5.9.3 Biogénesis-Bago Anthrax Vaccines Products Offered
5.9.4 Biogénesis-Bago Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Biogénesis-Bago Anthrax Vaccines Sales by Product in 2024
5.9.6 Biogénesis-Bago Anthrax Vaccines Sales by Application in 2024
5.9.7 Biogénesis-Bago Anthrax Vaccines Sales by Geographic Area in 2024
5.9.8 Biogénesis-Bago Recent Developments
5.10 CAVAC
5.10.1 CAVAC Company Information
5.10.2 CAVAC Description, Business Overview
5.10.3 CAVAC Anthrax Vaccines Products Offered
5.10.4 CAVAC Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.10.5 CAVAC Anthrax Vaccines Sales by Product in 2024
5.10.6 CAVAC Anthrax Vaccines Sales by Application in 2024
5.10.7 CAVAC Anthrax Vaccines Sales by Geographic Area in 2024
5.10.8 CAVAC Recent Developments
5.11 Rosenbusch
5.11.1 Rosenbusch Company Information
5.11.2 Rosenbusch Description, Business Overview
5.11.3 Rosenbusch Anthrax Vaccines Products Offered
5.11.4 Rosenbusch Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Rosenbusch Anthrax Vaccines Sales by Product in 2024
5.11.6 Rosenbusch Anthrax Vaccines Sales by Application in 2024
5.11.7 Rosenbusch Anthrax Vaccines Sales by Geographic Area in 2024
5.11.8 Rosenbusch Recent Developments
5.12 Agrovet
5.12.1 Agrovet Company Information
5.12.2 Agrovet Description, Business Overview
5.12.3 Agrovet Anthrax Vaccines Products Offered
5.12.4 Agrovet Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Agrovet Anthrax Vaccines Sales by Product in 2024
5.12.6 Agrovet Anthrax Vaccines Sales by Application in 2024
5.12.7 Agrovet Anthrax Vaccines Sales by Geographic Area in 2024
5.12.8 Agrovet Recent Developments
5.13 Vecol
5.13.1 Vecol Company Information
5.13.2 Vecol Description, Business Overview
5.13.3 Vecol Anthrax Vaccines Products Offered
5.13.4 Vecol Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Vecol Anthrax Vaccines Sales by Product in 2024
5.13.6 Vecol Anthrax Vaccines Sales by Application in 2024
5.13.7 Vecol Anthrax Vaccines Sales by Geographic Area in 2024
5.13.8 Vecol Recent Developments
5.14 CVCRI
5.14.1 CVCRI Company Information
5.14.2 CVCRI Description, Business Overview
5.14.3 CVCRI Anthrax Vaccines Products Offered
5.14.4 CVCRI Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.14.5 CVCRI Anthrax Vaccines Sales by Product in 2024
5.14.6 CVCRI Anthrax Vaccines Sales by Application in 2024
5.14.7 CVCRI Anthrax Vaccines Sales by Geographic Area in 2024
5.14.8 CVCRI Recent Developments
5.15 IVPM
5.15.1 IVPM Company Information
5.15.2 IVPM Description, Business Overview
5.15.3 IVPM Anthrax Vaccines Products Offered
5.15.4 IVPM Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.15.5 IVPM Anthrax Vaccines Sales by Product in 2024
5.15.6 IVPM Anthrax Vaccines Sales by Application in 2024
5.15.7 IVPM Anthrax Vaccines Sales by Geographic Area in 2024
5.15.8 IVPM Recent Developments
5.16 Prondil
5.16.1 Prondil Company Information
5.16.2 Prondil Description, Business Overview
5.16.3 Prondil Anthrax Vaccines Products Offered
5.16.4 Prondil Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.16.5 Prondil Anthrax Vaccines Sales by Product in 2024
5.16.6 Prondil Anthrax Vaccines Sales by Application in 2024
5.16.7 Prondil Anthrax Vaccines Sales by Geographic Area in 2024
5.16.8 Prondil Recent Developments
5.17 CDV
5.17.1 CDV Company Information
5.17.2 CDV Description, Business Overview
5.17.3 CDV Anthrax Vaccines Products Offered
5.17.4 CDV Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.17.5 CDV Anthrax Vaccines Sales by Product in 2024
5.17.6 CDV Anthrax Vaccines Sales by Application in 2024
5.17.7 CDV Anthrax Vaccines Sales by Geographic Area in 2024
5.17.8 CDV Recent Developments
5.18 Indian Immunologicals
5.18.1 Indian Immunologicals Company Information
5.18.2 Indian Immunologicals Description, Business Overview
5.18.3 Indian Immunologicals Anthrax Vaccines Products Offered
5.18.4 Indian Immunologicals Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.18.5 Indian Immunologicals Anthrax Vaccines Sales by Product in 2024
5.18.6 Indian Immunologicals Anthrax Vaccines Sales by Application in 2024
5.18.7 Indian Immunologicals Anthrax Vaccines Sales by Geographic Area in 2024
5.18.8 Indian Immunologicals Recent Developments
5.19 Botswana Vaccine Institute
5.19.1 Botswana Vaccine Institute Company Information
5.19.2 Botswana Vaccine Institute Description, Business Overview
5.19.3 Botswana Vaccine Institute Anthrax Vaccines Products Offered
5.19.4 Botswana Vaccine Institute Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.19.5 Botswana Vaccine Institute Anthrax Vaccines Sales by Product in 2024
5.19.6 Botswana Vaccine Institute Anthrax Vaccines Sales by Application in 2024
5.19.7 Botswana Vaccine Institute Anthrax Vaccines Sales by Geographic Area in 2024
5.19.8 Botswana Vaccine Institute Recent Developments
5.20 Ceva Santé Animale
5.20.1 Ceva Santé Animale Company Information
5.20.2 Ceva Santé Animale Description, Business Overview
5.20.3 Ceva Santé Animale Anthrax Vaccines Products Offered
5.20.4 Ceva Santé Animale Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.20.5 Ceva Santé Animale Anthrax Vaccines Sales by Product in 2024
5.20.6 Ceva Santé Animale Anthrax Vaccines Sales by Application in 2024
5.20.7 Ceva Santé Animale Anthrax Vaccines Sales by Geographic Area in 2024
5.20.8 Ceva Santé Animale Recent Developments
5.21 Intervac
5.21.1 Intervac Company Information
5.21.2 Intervac Description, Business Overview
5.21.3 Intervac Anthrax Vaccines Products Offered
5.21.4 Intervac Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.21.5 Intervac Anthrax Vaccines Sales by Product in 2024
5.21.6 Intervac Anthrax Vaccines Sales by Application in 2024
5.21.7 Intervac Anthrax Vaccines Sales by Geographic Area in 2024
5.21.8 Intervac Recent Developments
5.22 JOVAC
5.22.1 JOVAC Company Information
5.22.2 JOVAC Description, Business Overview
5.22.3 JOVAC Anthrax Vaccines Products Offered
5.22.4 JOVAC Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.22.5 JOVAC Anthrax Vaccines Sales by Product in 2024
5.22.6 JOVAC Anthrax Vaccines Sales by Application in 2024
5.22.7 JOVAC Anthrax Vaccines Sales by Geographic Area in 2024
5.22.8 JOVAC Recent Developments
6 North America
6.1 North America Anthrax Vaccines Market Size YoY Growth 2020-2031
6.2 North America Anthrax Vaccines Market Facts & Figures by Country
6.2.1 North America Anthrax Vaccines Sales by Country (2020-2031)
6.2.2 North America Anthrax Vaccines Revenue by Country (2020-2031)
6.3 North America Anthrax Vaccines Sales by Type (2020-2025)
6.4 North America Anthrax Vaccines Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Anthrax Vaccines Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Anthrax Vaccines Market Facts & Figures by Region
7.2.1 Asia-Pacific Anthrax Vaccines Sales by Region (2020-2031)
7.2.2 Asia-Pacific Anthrax Vaccines Revenue by Region (2020-2031)
7.3 Asia-Pacific Anthrax Vaccines Sales by Type (2020-2025)
7.4 Asia-Pacific Anthrax Vaccines Sales by Application (2020-2025)
8 Europe
8.1 Europe Anthrax Vaccines Market Size YoY Growth 2020-2031
8.2 Europe Anthrax Vaccines Market Facts & Figures by Country
8.2.1 Europe Anthrax Vaccines Sales by Country (2020-2031)
8.2.2 Europe Anthrax Vaccines Revenue by Country (2020-2031)
8.3 Europe Anthrax Vaccines Sales by Type (2020-2025)
8.4 Europe Anthrax Vaccines Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Anthrax Vaccines Market Size YoY Growth 2020-2031
9.2 Latin America Anthrax Vaccines Market Facts & Figures by Country
9.2.1 Latin America Anthrax Vaccines Sales by Country (2020-2031)
9.2.2 Latin America Anthrax Vaccines Revenue by Country (2020-2031)
9.3 Latin America Anthrax Vaccines Sales by Type (2020-2025)
9.4 Latin America Anthrax Vaccines Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Anthrax Vaccines Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Anthrax Vaccines Market Facts & Figures by Country
10.2.1 Middle East and Africa Anthrax Vaccines Sales by Country (2020-2031)
10.2.2 Middle East and Africa Anthrax Vaccines Revenue by Country (2020-2031)
10.3 Middle East and Africa Anthrax Vaccines Sales by Type (2020-2025)
10.4 Middle East and Africa Anthrax Vaccines Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Anthrax Vaccines Supply Chain Analysis
11.2 Anthrax Vaccines Key Raw Materials and Upstream Suppliers
11.3 Anthrax Vaccines Clients Analysis
11.4 Anthrax Vaccines Sales Channel and Sales Model Analysis
11.4.1 Anthrax Vaccines Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Anthrax Vaccines Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Anthrax Vaccines Distributors
12 Anthrax Vaccines Market Dynamics
12.1 Anthrax Vaccines Industry Trends
12.2 Anthrax Vaccines Market Drivers
12.3 Anthrax Vaccines Market Challenges
12.4 Anthrax Vaccines Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Emergent Biosolutions
Merial 
Merck
Zoetis Inc
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC
List of Tables
 Table 1. Global Anthrax Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Anthrax Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Anthrax Vaccines Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Anthrax Vaccines Sales by Region (2020-2025) & (M Doses)
 Table 5. Global Anthrax Vaccines Sales Forecast by Region (2026-2031) & (M Doses)
 Table 6. Global Anthrax Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Anthrax Vaccines Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Anthrax Vaccines Sales Volume by Type (2020-2025) & (M Doses)
 Table 9. Global Anthrax Vaccines Sales Volume by Type (2026-2031) & (M Doses)
 Table 10. Global Anthrax Vaccines Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Anthrax Vaccines Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Anthrax Vaccines Sales Volume by Application (2020-2025) & (M Doses)
 Table 13. Global Anthrax Vaccines Sales Volume by Application (2026-2031) & (M Doses)
 Table 14. Global Anthrax Vaccines Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Anthrax Vaccines Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Anthrax Vaccines Sales by Manufacturer (2020-2025) & (M Doses)
 Table 17. Global Anthrax Vaccines Sales Share by Manufacturer (2020-2025)
 Table 18. Anthrax Vaccines Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Anthrax Vaccines Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Anthrax Vaccines Price (2020-2025) & (USD/Dose)
 Table 21. Ranking of Global Top Anthrax Vaccines Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Anthrax Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Anthrax Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anthrax Vaccines as of 2024)
 Table 24. Anthrax Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Anthrax Vaccines Market
 Table 26. Manufacturers Anthrax Vaccines Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Emergent BioSolutions Company Information
 Table 29. Emergent BioSolutions Description and Business Overview
 Table 30. Emergent BioSolutions Anthrax Vaccines Product
 Table 31. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 32. Emergent BioSolutions Sales Proportion of Anthrax Vaccines by Product in 2024
 Table 33. Emergent BioSolutions Sales Proportion of Anthrax Vaccines by Application in 2024
 Table 34. Emergent BioSolutions Sales Proportion of Anthrax Vaccines by Geographic Area in 2024
 Table 35. Emergent BioSolutions Recent Developments
 Table 36. Merial Company Information
 Table 37. Merial Description and Business Overview
 Table 38. Merial Anthrax Vaccines Product
 Table 39. Merial Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 40. Merial Sales Proportion of Anthrax Vaccines by Product in 2024
 Table 41. Merial Sales Proportion of Anthrax Vaccines by Application in 2024
 Table 42. Merial Sales Proportion of Anthrax Vaccines by Geographic Area in 2024
 Table 43. Merial Recent Developments
 Table 44. Merck Company Information
 Table 45. Merck Description and Business Overview
 Table 46. Merck Anthrax Vaccines Product
 Table 47. Merck Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 48. Merck Sales Proportion of Anthrax Vaccines by Product in 2024
 Table 49. Merck Sales Proportion of Anthrax Vaccines by Application in 2024
 Table 50. Merck Sales Proportion of Anthrax Vaccines by Geographic Area in 2024
 Table 51. Merck Recent Developments
 Table 52. Zoetis Company Information
 Table 53. Zoetis Description and Business Overview
 Table 54. Zoetis Anthrax Vaccines Product
 Table 55. Zoetis Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 56. Zoetis Sales Proportion of Anthrax Vaccines by Product in 2024
 Table 57. Zoetis Sales Proportion of Anthrax Vaccines by Application in 2024
 Table 58. Zoetis Sales Proportion of Anthrax Vaccines by Geographic Area in 2024
 Table 59. Zoetis Recent Developments
 Table 60. Bayer Sanidad Animal Company Information
 Table 61. Bayer Sanidad Animal Description and Business Overview
 Table 62. Bayer Sanidad Animal Anthrax Vaccines Product
 Table 63. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 64. Bayer Sanidad Animal Sales Proportion of Anthrax Vaccines by Product in 2024
 Table 65. Bayer Sanidad Animal Sales Proportion of Anthrax Vaccines by Application in 2024
 Table 66. Bayer Sanidad Animal Sales Proportion of Anthrax Vaccines by Geographic Area in 2024
 Table 67. Bayer Sanidad Animal Recent Developments
 Table 68. Colorado Serum Company Information
 Table 69. Colorado Serum Description and Business Overview
 Table 70. Colorado Serum Anthrax Vaccines Product
 Table 71. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 72. Colorado Serum Sales Proportion of Anthrax Vaccines by Product in 2024
 Table 73. Colorado Serum Sales Proportion of Anthrax Vaccines by Application in 2024
 Table 74. Colorado Serum Sales Proportion of Anthrax Vaccines by Geographic Area in 2024
 Table 75. Colorado Serum Recent Developments
 Table 76. PharmAthene Company Information
 Table 77. PharmAthene Description and Business Overview
 Table 78. PharmAthene Anthrax Vaccines Product
 Table 79. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 80. PharmAthene Sales Proportion of Anthrax Vaccines by Product in 2024
 Table 81. PharmAthene Sales Proportion of Anthrax Vaccines by Application in 2024
 Table 82. PharmAthene Sales Proportion of Anthrax Vaccines by Geographic Area in 2024
 Table 83. PharmAthene Recent Developments
 Table 84. Tiankang Company Information
 Table 85. Tiankang Description and Business Overview
 Table 86. Tiankang Anthrax Vaccines Product
 Table 87. Tiankang Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 88. Tiankang Sales Proportion of Anthrax Vaccines by Product in 2024
 Table 89. Tiankang Sales Proportion of Anthrax Vaccines by Application in 2024
 Table 90. Tiankang Sales Proportion of Anthrax Vaccines by Geographic Area in 2024
 Table 91. Tiankang Recent Developments
 Table 92. Biogénesis-Bago Company Information
 Table 93. Biogénesis-Bago Description and Business Overview
 Table 94. Biogénesis-Bago Anthrax Vaccines Product
 Table 95. Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 96. Biogénesis-Bago Sales Proportion of Anthrax Vaccines by Product in 2024
 Table 97. Biogénesis-Bago Sales Proportion of Anthrax Vaccines by Application in 2024
 Table 98. Biogénesis-Bago Sales Proportion of Anthrax Vaccines by Geographic Area in 2024
 Table 99. Biogénesis-Bago Recent Developments
 Table 100. CAVAC Company Information
 Table 101. CAVAC Description and Business Overview
 Table 102. CAVAC Anthrax Vaccines Product
 Table 103. CAVAC Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 104. CAVAC Sales Proportion of Anthrax Vaccines by Product in 2024
 Table 105. CAVAC Sales Proportion of Anthrax Vaccines by Application in 2024
 Table 106. CAVAC Sales Proportion of Anthrax Vaccines by Geographic Area in 2024
 Table 107. CAVAC Recent Developments
 Table 108. Rosenbusch Company Information
 Table 109. Rosenbusch Description and Business Overview
 Table 110. Rosenbusch Anthrax Vaccines Product
 Table 111. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 112. Rosenbusch Sales Proportion of Anthrax Vaccines by Product in 2024
 Table 113. Rosenbusch Sales Proportion of Anthrax Vaccines by Application in 2024
 Table 114. Rosenbusch Sales Proportion of Anthrax Vaccines by Geographic Area in 2024
 Table 115. Rosenbusch Recent Developments
 Table 116. Agrovet Company Information
 Table 117. Agrovet Description and Business Overview
 Table 118. Agrovet Anthrax Vaccines Product
 Table 119. Agrovet Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 120. Agrovet Sales Proportion of Anthrax Vaccines by Product in 2024
 Table 121. Agrovet Sales Proportion of Anthrax Vaccines by Application in 2024
 Table 122. Agrovet Sales Proportion of Anthrax Vaccines by Geographic Area in 2024
 Table 123. Agrovet Recent Developments
 Table 124. Vecol Company Information
 Table 125. Vecol Description and Business Overview
 Table 126. Vecol Anthrax Vaccines Product
 Table 127. Vecol Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 128. Vecol Sales Proportion of Anthrax Vaccines by Product in 2024
 Table 129. Vecol Sales Proportion of Anthrax Vaccines by Application in 2024
 Table 130. Vecol Sales Proportion of Anthrax Vaccines by Geographic Area in 2024
 Table 131. Vecol Recent Developments
 Table 132. CVCRI Company Information
 Table 133. CVCRI Description and Business Overview
 Table 134. CVCRI Anthrax Vaccines Product
 Table 135. CVCRI Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 136. CVCRI Sales Proportion of Anthrax Vaccines by Product in 2024
 Table 137. CVCRI Sales Proportion of Anthrax Vaccines by Application in 2024
 Table 138. CVCRI Sales Proportion of Anthrax Vaccines by Geographic Area in 2024
 Table 139. CVCRI Recent Developments
 Table 140. IVPM Company Information
 Table 141. IVPM Description and Business Overview
 Table 142. IVPM Anthrax Vaccines Product
 Table 143. IVPM Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 144. IVPM Sales Proportion of Anthrax Vaccines by Product in 2024
 Table 145. IVPM Sales Proportion of Anthrax Vaccines by Application in 2024
 Table 146. IVPM Sales Proportion of Anthrax Vaccines by Geographic Area in 2024
 Table 147. IVPM Recent Developments
 Table 148. Prondil Company Information
 Table 149. Prondil Description and Business Overview
 Table 150. Prondil Anthrax Vaccines Product
 Table 151. Prondil Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 152. Prondil Sales Proportion of Anthrax Vaccines by Product in 2024
 Table 153. Prondil Sales Proportion of Anthrax Vaccines by Application in 2024
 Table 154. Prondil Sales Proportion of Anthrax Vaccines by Geographic Area in 2024
 Table 155. Prondil Recent Developments
 Table 156. CDV Company Information
 Table 157. CDV Description and Business Overview
 Table 158. CDV Anthrax Vaccines Product
 Table 159. CDV Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 160. CDV Sales Proportion of Anthrax Vaccines by Product in 2024
 Table 161. CDV Sales Proportion of Anthrax Vaccines by Application in 2024
 Table 162. CDV Sales Proportion of Anthrax Vaccines by Geographic Area in 2024
 Table 163. CDV Recent Developments
 Table 164. Indian Immunologicals Company Information
 Table 165. Indian Immunologicals Description and Business Overview
 Table 166. Indian Immunologicals Anthrax Vaccines Product
 Table 167. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 168. Indian Immunologicals Sales Proportion of Anthrax Vaccines by Product in 2024
 Table 169. Indian Immunologicals Sales Proportion of Anthrax Vaccines by Application in 2024
 Table 170. Indian Immunologicals Sales Proportion of Anthrax Vaccines by Geographic Area in 2024
 Table 171. Indian Immunologicals Recent Developments
 Table 172. Botswana Vaccine Institute Company Information
 Table 173. Botswana Vaccine Institute Description and Business Overview
 Table 174. Botswana Vaccine Institute Anthrax Vaccines Product
 Table 175. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 176. Botswana Vaccine Institute Sales Proportion of Anthrax Vaccines by Product in 2024
 Table 177. Botswana Vaccine Institute Sales Proportion of Anthrax Vaccines by Application in 2024
 Table 178. Botswana Vaccine Institute Sales Proportion of Anthrax Vaccines by Geographic Area in 2024
 Table 179. Botswana Vaccine Institute Recent Developments
 Table 180. Ceva Santé Animale Company Information
 Table 181. Ceva Santé Animale Description and Business Overview
 Table 182. Ceva Santé Animale Anthrax Vaccines Product
 Table 183. Ceva Santé Animale Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 184. Ceva Santé Animale Sales Proportion of Anthrax Vaccines by Product in 2024
 Table 185. Ceva Santé Animale Sales Proportion of Anthrax Vaccines by Application in 2024
 Table 186. Ceva Santé Animale Sales Proportion of Anthrax Vaccines by Geographic Area in 2024
 Table 187. Ceva Santé Animale Recent Developments
 Table 188. Intervac Company Information
 Table 189. Intervac Description and Business Overview
 Table 190. Intervac Anthrax Vaccines Product
 Table 191. Intervac Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 192. Intervac Sales Proportion of Anthrax Vaccines by Product in 2024
 Table 193. Intervac Sales Proportion of Anthrax Vaccines by Application in 2024
 Table 194. Intervac Sales Proportion of Anthrax Vaccines by Geographic Area in 2024
 Table 195. Intervac Recent Developments
 Table 196. JOVAC Company Information
 Table 197. JOVAC Description and Business Overview
 Table 198. JOVAC Anthrax Vaccines Product
 Table 199. JOVAC Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 200. JOVAC Sales Proportion of Anthrax Vaccines by Product in 2024
 Table 201. JOVAC Sales Proportion of Anthrax Vaccines by Application in 2024
 Table 202. JOVAC Sales Proportion of Anthrax Vaccines by Geographic Area in 2024
 Table 203. JOVAC Recent Developments
 Table 204. North America Anthrax Vaccines Sales by Country (2020-2025) & (M Doses)
 Table 205. North America Anthrax Vaccines Sales by Country (2026-2031) & (M Doses)
 Table 206. North America Anthrax Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 207. North America Anthrax Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 208. North America Anthrax Vaccines Sales by Type (2020-2025) & (M Doses)
 Table 209. North America Anthrax Vaccines Sales by Application (2020-2025) & (M Doses)
 Table 210. Asia-Pacific Anthrax Vaccines Sales by Region (2020-2025) & (M Doses)
 Table 211. Asia-Pacific Anthrax Vaccines Sales by Region (2026-2031) & (M Doses)
 Table 212. Asia-Pacific Anthrax Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 213. Asia-Pacific Anthrax Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 214. Asia-Pacific Anthrax Vaccines Sales by Type (2020-2025) & (M Doses)
 Table 215. Asia-Pacific Anthrax Vaccines Sales by Application (2020-2025) & (M Doses)
 Table 216. Europe Anthrax Vaccines Sales by Country (2020-2025) & (M Doses)
 Table 217. Europe Anthrax Vaccines Sales by Country (2026-2031) & (M Doses)
 Table 218. Europe Anthrax Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 219. Europe Anthrax Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 220. Europe Anthrax Vaccines Sales by Type (2020-2025) & (M Doses)
 Table 221. Europe Anthrax Vaccines Sales by Application (2020-2025) & (M Doses)
 Table 222. Latin America Anthrax Vaccines Sales by Country (2020-2025) & (M Doses)
 Table 223. Latin America Anthrax Vaccines Sales by Country (2026-2031) & (M Doses)
 Table 224. Latin America Anthrax Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 225. Latin America Anthrax Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 226. Latin America Anthrax Vaccines Sales by Type (2020-2025) & (M Doses)
 Table 227. Latin America Anthrax Vaccines Sales by Application (2020-2025) & (M Doses)
 Table 228. Middle East and Africa Anthrax Vaccines Sales by Country (2020-2025) & (M Doses)
 Table 229. Middle East and Africa Anthrax Vaccines Sales by Country (2026-2031) & (M Doses)
 Table 230. Middle East and Africa Anthrax Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 231. Middle East and Africa Anthrax Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 232. Middle East and Africa Anthrax Vaccines Sales by Type (2020-2025) & (M Doses)
 Table 233. Middle East and Africa Anthrax Vaccines Sales by Application (2020-2025) & (M Doses)
 Table 234. Anthrax Vaccines Key Raw Materials, Industry Status and Trend
 Table 235. Anthrax Vaccines Key Raw Materials and Upstream Suppliers
 Table 236. Anthrax Vaccines Clients Status and Trend
 Table 237. Anthrax Vaccines Typical Clients
 Table 238. Anthrax Vaccines Distributors
 Table 239. Anthrax Vaccines Market Trends
 Table 240. Anthrax Vaccines Market Drivers
 Table 241. Anthrax Vaccines Market Challenges
 Table 242. Anthrax Vaccines Market Restraints
 Table 243. Research Programs/Design for This Report
 Table 244. Key Data Information from Secondary Sources
 Table 245. Key Data Information from Primary Sources
 Table 246. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Anthrax Vaccines Product Picture
 Figure 2. Global Anthrax Vaccines Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Anthrax Vaccines Sales Market Share by Type in 2024 & 2031
 Figure 4. Live Vaccines Product Picture
 Figure 5. Cell free PA Vaccines Product Picture
 Figure 6. Global Anthrax Vaccines Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Anthrax Vaccines Sales Market Share by Application in 2024 & 2031
 Figure 8. Human Use
 Figure 9. Animal Use
 Figure 10. Anthrax Vaccines Report Years Considered
 Figure 11. Global Anthrax Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Anthrax Vaccines Market Size 2020-2031 (US$ Million)
 Figure 13. Global Anthrax Vaccines Sales 2020-2031 (M Doses)
 Figure 14. Global Anthrax Vaccines Sales Market Share Forecast by Region (2020-2031)
 Figure 15. Global Anthrax Vaccines Revenue Market Share by Region (2020-2031)
 Figure 16. Global Anthrax Vaccines Sales Market Share Forecast by Type (2020-2031)
 Figure 17. Global Anthrax Vaccines Revenue Market Share Forecast by Type (2020-2031)
 Figure 18. Anthrax Vaccines Average Selling Price (ASP) by Type (2020-2025) & (USD/Dose)
 Figure 19. Global Anthrax Vaccines Sales Market Share Forecast by Application (2020-2031)
 Figure 20. Global Anthrax Vaccines Revenue Market Share Forecast by Application (2020-2031)
 Figure 21. Anthrax Vaccines Average Selling Price (ASP) by Application (2020-2025) & (USD/Dose)
 Figure 22. Live Vaccines of Anthrax Vaccines Revenue Market Share by Application, 2024 VS 2031
 Figure 23. Cell free PA Vaccines of Anthrax Vaccines Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Global Anthrax Vaccines Sales Share by Manufacturer in 2024
 Figure 25. Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Live Vaccines Market Sales Proportion by Manufacturer in 2024
 Figure 27. Cell free PA Vaccines Market Sales Proportion by Manufacturer in 2024
 Figure 28. North America Anthrax Vaccines Revenue 2020-2031 (US$ Million)
 Figure 29. North America Anthrax Vaccines Sales Market Share by Type (2020-2025)
 Figure 30. North America Anthrax Vaccines Sales Market Share by Application (2020-2025)
 Figure 31. Asia-Pacific Anthrax Vaccines Revenue 2020-2031 (US$ Million)
 Figure 32. Asia-Pacific Anthrax Vaccines Sales Market Share by Region (2020-2031)
 Figure 33. Asia-Pacific Anthrax Vaccines Revenue Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific Anthrax Vaccines Sales Market Share by Type (2020-2025)
 Figure 35. Asia-Pacific Anthrax Vaccines Sales Market Share by Application (2020-2025)
 Figure 36. Europe Anthrax Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 37. Europe Anthrax Vaccines Sales Market Share by Country (2020-2031)
 Figure 38. Europe Anthrax Vaccines Revenue Market Share by Country (2020-2031)
 Figure 39. Europe Anthrax Vaccines Sales Market Share by Type (2020-2025)
 Figure 40. Europe Anthrax Vaccines Sales Market Share by Application (2020-2025)
 Figure 41. Latin America Anthrax Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Latin America Anthrax Vaccines Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Anthrax Vaccines Revenue Market Share by Country (2020-2025)
 Figure 44. Latin America Anthrax Vaccines Sales Market Share by Type (2020-2025)
 Figure 45. Latin America Anthrax Vaccines Sales Market Share by Application (2020-2025)
 Figure 46. Middle East and Africa Anthrax Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 47. Middle East and Africa Anthrax Vaccines Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Anthrax Vaccines Revenue Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Anthrax Vaccines Sales Market Share by Type (2020-2025)
 Figure 50. Middle East and Africa Anthrax Vaccines Sales Market Share by Application (2020-2025)
 Figure 51. Anthrax Vaccines Supply Chain (Upstream and Downstream Market)
 Figure 52. Global Production Market Share of Anthrax Vaccines Raw Materials by Region in 2024
 Figure 53. Anthrax Vaccines Distribution Channels
 Figure 54. Global Anthrax Vaccines Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 55. Global Anthrax Vaccines Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Veterinary Anthrax Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biothrax Anthrax Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anthrax Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Animal Vaccines Market Insights Forecast to 2030
Global Animal Anti Rabies Vaccine Market Research Report 2024
Global Brucellosis Vaccines Market Research Report 2025
Global Abthrax Market Insights Forecast to 2030
Global Antibacterial Vaccines Market Research Report 2024
Ruminant Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Farm Animal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bacterial Vaccines for Humans Market Research Report 2024
Cattle and Sheep Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global TB Vaccines Market Insights Forecast to 2030
Global Pneumonia Vaccine Market Insights Forecast to 2030
Global Livestock Animal Vaccines Market Research Report 2024
Global Travel Vaccines Market Insights Forecast to 2030
Global Dog Vaccines Market Insights Forecast to 2030
Rabies Vaccines for Animals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Livestock Animal Vaccination Market Research Report 2025

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions